Paper · 38807663
Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients.
Zhao K and 2 others. Oncol Lett, 2024. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients. Papers, record 38807663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38807663
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Panoramic RNA expression of fibroblast growth factors in human glioblastoma tissues and the impact on the survival of patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,333,730 | The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24333730 | PubMed |
| 2 | 35,681,108 | Metabolic Messengers: fibroblast growth factor 1. | Nat Metab | 2022 | https://conductscience.org/library/papers/35681108 | PubMed |
| 3 | 25,772,309 | The Fibroblast Growth Factor signaling pathway. | Wiley Interdiscip Rev Dev Biol | 2015 | https://conductscience.org/library/papers/25772309 | PubMed |
| 4 | 25,566,961 | Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer. | Tumour Biol | 2015 | https://conductscience.org/library/papers/25566961 | PubMed |
| 5 | 23,385,422 | Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model. | Cell Mol Neurobiol | 2013 | https://conductscience.org/library/papers/23385422 | PubMed |
| 6 | 25,407,308 | Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer. | Mol Biol Rep | 2015 | https://conductscience.org/library/papers/25407308 | PubMed |
| 7 | 34,757,019 | Glioma cell-derived FGF20 suppresses macrophage function by activating β-catenin. | Cell Signal | 2022 | https://conductscience.org/library/papers/34757019 | PubMed |
| 8 | 33,664,496 | Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. | Nat Cell Biol | 2021 | https://conductscience.org/library/papers/33664496 | PubMed |
| 9 | 12,626,354 | Fibroblast growth factors as regulators of central nervous system development and function. | Am J Physiol Regul Integr Comp Physiol | 2003 | https://conductscience.org/library/papers/12626354 | PubMed |
| 10 | 35,545,674 | Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17. | Nature | 2022 | https://conductscience.org/library/papers/35545674 | PubMed |
1 to 10 of 45
See all 45 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,901,917 | Identification and validation of NCOA5-ZCCHC3/FGF22 axis as a prognostic marker in lung adenocarcinoma migration and invasion. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42901917 | PubMed |
| 41,408,565 | GALNT3 is a novel target driving lymphomagenesis via O-glycosylation of FGFR2. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41408565 | PubMed |
| 40,478,501 | Engineering overexpressing SYNGR1 inhibited the progression of GBM cells by suppressing the intracellular FGF1-mediated LDs accumulation and cytoskeleton remodeling. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40478501 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF1 | 2,246 | PubTator's text mining | https://conductscience.org/library/genes/2246 | NCBI Gene |
| FGF17 | 8,822 | PubTator's text mining | https://conductscience.org/library/genes/8822 | NCBI Gene |
| FGF20 | 26,281 | PubTator's text mining | https://conductscience.org/library/genes/26281 | NCBI Gene |
| FGF22 | 27,006 | PubTator's text mining | https://conductscience.org/library/genes/27006 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38807663
GET https://conductscience.org/api/papers/v1/38807663/references?page=2